提出最好的候选人

非GLP毒理学和药理学

联系我们

使用我们的集成铅优化毒理学解决方案,将时间缩短至40天

Get the right study design working with a cross-functional team of experts

提前预测和应对挑战-以便更好地做出决策

提高技术成功的概率

你已经知道在你的早期发育过程中你需要毒理学研究。但多早?越早越好。通过启动非GLP毒理学研究,在后期经历一半的分子磨损your体内工作。我们的更短的预期和后期后的时间将您的日程安排减少到40天,帮助您迅速识别您的最佳候选人。

Novel Compounds Require Novel Approaches

As you progress in your development journey, let us be your partner. We offer flexible design options, across multiple species, to help you determine which variables are the most crucial to isolate. By leveraging our integrated team of pharmacologists and pathologists, we help you find the right study solutions.

See the Unforeseen and Respond Accordingly

早期开发的特点是出现了一些意想不到的问题,这些问题可能会使您在以后的阶段脱轨。通过我们的综合方法,我们可以帮助您科学地预测挑战并快速应对。通过将药理学、影像学和病理学整合到毒理学研究中,您可以在旅程中更早、更经济地主动解决问题。

Non-GLP Studies Toxicology Benefits


Make Better Decisions Earlier with an Integrated Team

Our cross-functional team of experts is prepared to anticipate and respond to challenges early so you can make well-informed decisions.

Get Efficiently Executed non-GLP Toxicology Studies Across a Wide Range of Research Models:

  • 关于监管要求和非界面研究的咨询
  • 内分泌功能评估
  • 在有意识/无拘无束的动物中的心血管功能评估
  • 铅优化毒理学
    • 大动物剂量递增和初步研究
    • 大、小动物剂量范围研究
    • Rodent screening and pilot studies
    • 大、小动物的毒代动力学研究

Understand Your Compound’s Safety Profile With Pharmacology Studies:

  • 非临床,非GLP,心血管功能表征
  • 临床convulsive risk nonclinical strategies
  • Endocrine function evaluation
  • Safety margin characterizations relative to therapeutic effects
  • 受体占有分析有助于指导决策
  • 管理的consultation on nonclinical studies

相关章节

Let's start a conversation

联系我们